Jose-Ignacio Rodriguez-Barbosa
8PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 05, 2025
Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma.Vicent Tur-Planells, Yonina Bykov, Gloria Dawodu
|Jun 02, 2025
A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth.Maria-Luisa Del Rio, Oscar-Mariano Nuero-Garcia, Giovanna Roncador
|May 14, 2020
The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.Jose-Ignacio Rodriguez-Barbosa, Pascal Schneider, Luis Graca
|Feb 24, 2020
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model.Jose-Ignacio Rodriguez-Barbosa, Miyuki Azuma, Gennadiy Zelinskyy
|Jun 05, 2019
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.Jose Ignacio Rodriguez-Barbosa, Pascal Schneider, Andreas Weigert
|Jan 13, 2019
Correction to: T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.Jose-Ignacio Rodriguez-Barbosa, Carlos Fernandez-Renedo, Ana María Bravo Moral
Pageof 2
Frequent Collaborators
5 joint publications
María-Luisa Del Río
2 joint publications
Pascal Schneider
2 joint publications
Andreas Weigert
1 joint publications
L Buhler
1 joint publications
J A Perez-Simon
1 joint publications
Bernhard Brüne
1 joint publications
Kyung-Mi Lee
1 joint publications
Miyuki Azuma
1 joint publications
Gennadiy Zelinskyy
1 joint publications
Jose-Antonio Perez-Simon
